Pressure BioSciences' Q3 Revenues Increase 17 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences today announced a 17 percent increase in third-quarter revenues as grant revenues rose 57 percent.

For the three months ended Sept. 30, the sample prep technology firm reported total revenues of $372,103, up from $317,427 a year ago, falling short of Wall Street estimates of $420,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.